logo

For the Inventor, By the Inventor

Hong Kong, China

Hongjie Zhang

This inventor holds 20 USPTO granted patents and 2 published patent applications and 3 EPO patents, primarily in Anticancer Agents. Top assignees: Hong Kong Baptist University, University of Illinois, Other. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hongjie Zhang. Retrieved from https://idiyas.com/inventor/hongjie-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 95.0

 

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:

goldMedal19 out of 127 
 
Hong Kong Baptist University
 patents
silverMedal1 out of 2,430 
 
University of Illinois
 patents
bronzeMedal1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Antiviral Agents
Diterpenoid Derivatives
Cyclic Peptides
Miliusanes
Dihydro-Resveratrol
Anticancer
Skin-Protection
Fibrotic Conditions
Obesity Treatment
Stilbenoid Derivatives
Tumorous Pathologies
Flavanol Glycosides
20 patents (USPTO):Explore Patents
1. 12337007 - Patentiflorin A analogs as antiviral agents (2025-06-24),
2. 11638713 - Patentiflorin A analogs as antiviral agents (2023-05-02),
3. 10493056 - Method of use of diterpenoid derivatives as anticancer agents (2019-12-03),
4. 10351500 - Method of using of dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants as antimicrobial agents (2019-07-16),
5. 10323012 - Miliusanes as antiviral agents (2019-06-18),
6. 10188590 - [object Object] (2019-01-29),
7. 10017442 - Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatment of tumorous pathologies (2018-07-10),
8. 9963485 - Cycloheptapeptide agents for treatment of cancer and obesity diseases (2018-05-08),
9. 9956152 - Skin-protection composition containing dendrobium-based ingredients (2018-05-01),
10. 9877931 - Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions (2018-01-30),
11. 9822071 - Anticancer miliusane lactams (2017-11-21),
12. 9795589 - Method of use of diterpenoid derivatives as anticancer agents (2017-10-24),
13. 9738581 - Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions (2017-08-22),
14. 9695141 - Anticancer miliusane derivatives (2017-07-04),
15. 9562059 - Anticancer maytansinoids with two fused macrocyclic rings (2017-02-07),

Title: Inventor Hongjie Zhang

Introduction: Hongjie Zhang is a renowned inventor based in Hong Kong, China, known for his groundbreaking contributions to various technological fields.

Latest Patents: Hongjie Zhang holds several patents in the areas of nanotechnology, renewable energy, and biomedicine, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Zhang has worked with leading research institutions and universities to develop cutting-edge technologies that have the potential to revolutionize industries worldwide.

Collaborations: Throughout his career, Hongjie Zhang has collaborated with top companies, scientists, and inventors globally, fostering a culture of innovation and knowledge sharing in the scientific community.

Conclusion: Hongjie Zhang's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and researchers around the world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…